Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma

Glioblastoma (GBM) is a devasting primary brain tumor with less than a 5% 5-year survival. Treatment response assessment can be challenging because of inflammatory pseudoprogression that mimics true tumor progression clinically and on imaging. Developing additional noninvasive assays is critical. In...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurosurgical focus 2022-12, Vol.53 (6), p.E14-E14
Hauptverfasser:	Bauman, Megan M J, Bouchal, Samantha M, Monie, Dileep D, Aibaidula, Abudumijiti, Singh, Rohin, Parney, Ian F
Format:	Artikel
Sprache:	eng
Schlagworte:	Biopsy Glioblastoma - diagnostic imaging Glioblastoma - genetics Humans Liquid Biopsy Precision Medicine Proteomics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!